HITS researcher is Schiemann Fellow of the Max Planck Society

2. July 2021

Ganna (Anya) Gryn’ova, head of the Computational Carbon Chemistry (CCC) group at HITS, has been elected as Schiemann Fellow of …

Read more

Using Bioinformatics algorithms to predict the European Football Championship

25. June 2021

Researchers from the Computational Molecular Evolution (CME) group at HITS have simulated the knock-out phase of the European Football Championship using …

Read more

The MBM video contest winner is …

14. June 2021

Have you ever tried to explain complex scientific findings just with words? We all know how important clear and memorable scientific …

Read more

On the front cover: Brownian Dynamics Simulations of Proteins in the Presence of Surfaces

9. June 2021

Brownian dynamics simulations are well-suited to study processes governed by diffusion, such as the adsorption of protein molecules to a mica …

Read more

Welcome Chris!

7. June 2021

A warm welcome to Christoph who has recently joined the MBM group. Here are a few words from Christoph about himself: …

Read more

Welcome Jannik!

1. June 2021

A warm welcome to Jannik who has recently (re-)joined the MBM group. Here are a few words from Jannik about …

Read more

Investigating cancer development with the help of mathematics

28. May 2021

Scientists from Heidelberg have found a way to trace cancer formation using mathematical models. The results have now been published in …

Read more

The good, the bad, and the spaghetti code: Software put to the test

21. May 2021

Computer scientists at HITS and KIT Karlsruhe have developed “SoftWipe”, a largely automated open source tool and benchmark to assess the …

Read more

Traps and code: assessing insect biodiversity in Southern Crete

16. April 2021

HITS group leader Alexandros Stamatakis (Computational Molecular Evolution) is one of the coordinators in a citizen science project to asses insect …

Read more

Putting computing power together against SARS-CoV-2

12. April 2021

European scientists identified potent inhibitors of the SARS-CoV-2 main protease, a promising target for antiviral compounds.

Read more

Switch to the German homepage or stay on this page